Garza I, Schwedt TJ. Diagnosis and Management of Chronic Daily Headache. Semin Neurol. 2010;30(02):154–66.

Article  PubMed  Google Scholar 

Sheikh HU. Approach to chronic daily headache. Curr Neurol Neurosci Rep. 2015;15:1–6.

Article  Google Scholar 

Pascual J, Colás R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep. 2001;5(6):529–36.

Article  CAS  PubMed  Google Scholar 

Dodick DW. Chronic daily headache. N Engl J Med. 2006;354(2):158–65.

Article  CAS  PubMed  Google Scholar 

Lantéri-Minet M, et al. Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia. 2011;31(7):837–50.

Article  PubMed  Google Scholar 

Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol. 2000;13(3):277–83.

Article  CAS  PubMed  Google Scholar 

Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology. 1996;47(4):871–5.

Article  CAS  PubMed  Google Scholar 

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.

Yancey JR, Sheridan R, Koren KG. Chronic daily headache: diagnosis and management. Am Fam Physician. 2014;89(8):642–8.

PubMed  Google Scholar 

Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol. 2012;52(1):6–17.

Article  CAS  PubMed  Google Scholar 

Silberstein SD, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double‐blind, placebo‐controlled trial. Headache J Head Face Pain. 2007;47(2):170–80.

Article  Google Scholar 

Rothrock JF, et al. Predictors of a negative response to topiramate therapy in patients with chronic migraine. Headache J Head Face Pain. 2005;45(7):932–5.

Article  Google Scholar 

Scheffler A, et al. CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience. J Headache Pain. 2021;22(1):1–6.

Article  Google Scholar 

Lipton RB, et al. Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2. Neurology. 2020;94(13):e1365–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ornello R, et al. Early management of onabotulinumtoxinA treatment in chronic migraine: insights from a Real-Life European Multicenter Study. Pain Ther. 2021;10:637–50.

Article  PubMed  PubMed Central  Google Scholar 

Urits I, et al. CGRP antagonists for the treatment of chronic migraines: a comprehensive review. Curr Pain Headache Rep. 2019;23:1–10.

Article  Google Scholar 

Coppola G, et al. Neuromodulation for chronic daily headache. Curr Pain Headache Rep. 2022;26(3):267–78.

Article  PubMed  PubMed Central  Google Scholar 

• AbdElkader AA, et al. The efficacy of repetitive transcranial magnetic stimulation in treating patients with chronic daily headache. Egypt J Neurol Psychiatr Neurosurg. 2021;57:1–7. This is the only RCT conducted on chronic daily headaches as a whole. All the other included studies considered a particular type of chronic daily headache.

Article  Google Scholar 

Chail A, et al. Transcranial magnetic stimulation: a review of its evolution and current applications. Ind Psychiatry J. 2018;27(2):172.

Article  PubMed  PubMed Central  Google Scholar 

Lefaucheur JP, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2020;131(2):474–528.

Article  PubMed  Google Scholar 

Rosa MA, Lisanby SH. Somatic treatments for mood disorders. Neuropsychopharmacology. 2012;37(1):102–16.

Article  CAS  PubMed  Google Scholar 

Mansur C, et al. A sham stimulation-controlled trial of rTMS of the unaffected hemisphere in stroke patients. Neurology. 2005;64(10):1802–4.

Article  CAS  PubMed  Google Scholar 

Peinemann A, et al. Long-lasting increase in corticospinal excitability after 1800 pulses of subthreshold 5 Hz repetitive TMS to the primary motor cortex. Clin Neurophysiol. 2004;115(7):1519–26.

Article  PubMed  Google Scholar 

Bestmann S, et al. Functional MRI of the immediate impact of transcranial magnetic stimulation on cortical and subcortical motor circuits. Eur J Neurosci. 2004;19(7):1950–62.

Article  PubMed  Google Scholar 

Graff-Guerrero A, et al. Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex increases tolerance to human experimental pain. Cogn Brain Res. 2005;25(1):153–60.

Article  Google Scholar 

Fierro B, et al. Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex (DLPFC) during capsaicin-induced pain: modulatory effects on motor cortex excitability. Exp Brain Res. 2010;203:31–8.

Article  ADS  PubMed  Google Scholar 

Yoo W-K, et al. High frequency rTMS modulation of the sensorimotor networks: behavioral changes and fMRI correlates. Neuroimage. 2008;39(4):1886–95.

Article  PubMed  Google Scholar 

Boyer L, et al. rTMS in fibromyalgia: a randomized trial evaluating QoL and its brain metabolic substrate. Neurology. 2014;82(14):1231–8.

Article  CAS  PubMed  Google Scholar 

Brighina F, et al. rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci. 2004;227(1):67–71.

Article  PubMed  Google Scholar 

Kalita J, et al. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache. J Neurol. 2016;263(11):2238–46.

Article  PubMed  Google Scholar 

Seminowicz DA, Moayedi M. The dorsolateral prefrontal cortex in acute and chronic pain. J Pain. 2017;18(9):1027–35.

Article  PubMed  PubMed Central  Google Scholar 

Moisset X, de Andrade DC, Bouhassira D. From pulses to pain relief: An update on the mechanisms of rTMS-induced analgesic effects. Eur J Pain. 2016;20(5):689–700.

Article  CAS  PubMed  Google Scholar 

Misra UK, et al. Role of β endorphin in pain relief following high rate repetitive transcranial magnetic stimulation in migraine. Brain Stimul. 2017;10(3):618–23.

Article  PubMed  Google Scholar 

Keck M, et al. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology. 2002;43(1):101–9.

Article  CAS  PubMed  Google Scholar 

Strafella AP, et al. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci. 2001;21(15):RC157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Michael N, et al. Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. Eur J Neurosci. 2003;17(11):2462–8.

Article  PubMed  Google Scholar 

Ueyama E, et al. Chronic repetitive transcranial magnetic stimulation increases hippocampal neurogenesis in rats. Psychiatry Clin Neurosci. 2011;65(1):77–81.

Article  PubMed  Google Scholar 

Conforto AB, et al. Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine. Cephalalgia. 2014;34(6):464–72.

Article  PubMed  Google Scholar 

Granato A, et al. Dramatic placebo effect of high frequency repetitive TMS in treatment of chronic migraine and medication overuse headache. J Clin Neurosci. 2019;60:96–100.

Article  PubMed  Google Scholar 

Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.

Article  PubMed  PubMed Central  Google Scholar 

Sauro KM, et al. HIT‐6 and MIDAS as measures of headache disability in a headache referral population. Headache J Head Face Pain. 2010;50(3):383–95.

Article  Google Scholar 

Norman GR, Sloan JA, and Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582-592.

Lemieux J, et al. Three methods for minimally important difference: no relationship was found with the net proportion of patients improving. J Clin Epidemiol. 2007;60(5):448–55.

Article  PubMed  Google Scholar 

Silberstein SD, et al. Headache prophylaxis with BoNTA: patient characteristics. Headache J Head Face Pain. 2010;50(1):53–70.